 NESS ZIONA, Israel, Nov. 09, 2021 GLOBE NEWSWIRE -- Sol-Gel Technologies, Ltd. Nasdaq: SLGL, a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the Company will participate in the Jefferies London Healthcare Conference, taking place in-person on November 16th and 17th, 2021. 